Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

2Q Pharma Results Preview: Pfizer, Shire, Merck KGaA, Teva, Novo Nordisk And Allergan

Executive Summary

Pfizer, Merck KGaA, Novo Nordisk, Shire, Allergan and Teva are among those pharmaceutical majors still to report their 2Q results. Scrip considers what’s in store.

Advertisement

Related Content

Shire Backs Hemophilia Focus With Asset Updates, Irish iPATH Study
German Merck Aims To Lift Its UK R&D Efforts, Despite Brexit Uncertainty
2Q Preview: GSK, Bayer, Celgene, Amgen, AZ, BMS, Sanofi, Merck, Abbvie
Could Pfizer Choose To Consciously Stay Coupled?
Novo's CSO Has A Lifetime Product Plan For Diabetes Patients
2Q Pharma Results Preview: What Lies Ahead
German Merck Identifies Pipeline Stars, Plots Course Through A Dynamic Cancer Space
ADA: Victoza's 'Broad' CV Benefit Leads The Way For Semaglutide
Shire's Ornskov Maps Out Future Prospects Post- Baxalta Merger
Merck KGaA's Cladribine Revival Smacks Of Desperation

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

SC096973

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel